Associate Scientist In Vivo Pharmacology (Contract Position)
This is what you will do:
You will be working under the supervision of the in vivo Pharmacology Group Leader and will primarily be responsible for generating pre-clinical in vivo data by testing novel small molecule therapies and immunotherapies in clinically relevant mouse cancer models. The role involves supporting primary pharmacology and translational pharmacology programs by identifying and characterizing new cancer therapeutics using various cell lines and genetically engineered in vivo models. This person will determine the optimal doses, routes of administration and dose schedules, prioritize indications, identify biomarkers, elucidate mechanisms of resistance and identify efficacious combinations. The daily activities will include implanting, ear tagging, measuring, and dosing (PO, IP, IV) of various mouse cancer models, collecting tissues, formulating drugs, and providing in vitro and ex vivo support.
You will be responsible for:
Supporting drug discovery projects with relevant in vivo assays and generating primary data packages.
Executing in vivo pharmacology studies in mice (tumor growth inhibition, pharmacodynamic, pharmacokinetic and novel model growth curves).
Use gain-of-function (over expression) and loss-of-function (RNAi, CRISPR/Cas) approaches to study gene function in various in vivo models.
Identifying effective combinations with chemotherapies, targeted therapies or immune-modulatory agents.
Identifying clinically-tractable biomarkers that may guide patient selection or early-stage drug development.
Maintaining vivarium equipment, detailed laboratory files and an electronic notebook.
Presenting in lab meetings to inform and discuss progress, results and future studies.
You will need to have:
A Bachelor’s degree in a science-related field with direct animal research or two-years of direct animal research experience with no degree required
Experience in rodent handling and procedures, especially in cancer pharmacology
Experience in general laboratory techniques
Highly organized with excellent communication skills
Expertise in Microsoft Office Suite
Must be willing to work off-hours, weekends and holidays at times to support research needs.
The duties of this role are generally conducted in an lab environment. As is typical of a lab-based role, employees must be able, with or without an accommodation to: lift/carry 15/30 pounds unassisted/assisted; work comfortably in a controlled environment with and around biological, infectious, and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving and non-linear thought, analysis, and dialogue; collaborate with others; maintain general availability during standard business hours.
Mirati is seeking an experienced paralegal to assist with our day-to-day intellectual property and contracting needs. The ideal candidate should have significant experience assisting in the generation and filing of patent and trademark applications and related documents, docketing and facilitating patent and trademark workflow, and working with in-house and outside IP counsel to develop high-quality patents and trademarks. The ideal candidate should also have significant experience drafting, negotiating, and managing a variety of agreements for pharmaceutical and life sciences companies, including clinical trial agreements, non-disclosure agreements, master services agreements and consulting agreements. The successful candidate must be able to work independently to draft, revise and negotiate agreements, with a flexible and collaborative approach.
Your Responsibilities
Docket patent- and trademark-related correspondence. Generate docket reports using docketing software. Review docket reports to ensure timely provision of instructions to US and foreign agents.
Interact with in-house IP counsel, outside US and foreign patent counsel, and partners’ patent counsel to facilitate smooth, accurate and prompt handling of patent and trademark matters.
Assist in drafting/assembly/execution of patent applications and patent prosecution documents, including formal papers (assignments, declarations).
Draft, review and negotiate day-to-day contracts, including non-disclosure agreements, master service agreements, consulting agreements, clinical trial agreements and other clinical documents, independently and with limited supervision.
Manage contract negotiations to conclude agreements as efficiently as possible while meeting client needs and safeguarding Mirati’s interests.
Review and comment on IP terms in a broad array of agreements.
Address legal concerns of business groups across the company and coordinate cross-functionally with business groups including finance/accounting, clinical science, medical affairs and research.
Complete projects and special assignments, as needed.
What is Required
At least 8 years’ experience as a paralegal in the pharmaceutical, life sciences or biotechnology industry, and/or law firms servicing those industries.
Paralegal certification preferred; California notary preferred.
Experience in MS Office product suite (Excel, PowerPoint, WORD, VISIO), Adobe and DocuSign, and contract management systems (Agiloft preferred).
Strong knowledge of patent and trademark prosecution workflow and processes.
Experience in patent and trademark docketing procedures, and related software.
Familiarity with clinical research process.
Capable of reviewing complex agreements, with an understanding of when to escalate sensitive areas or issues for further consideration or specialist review.
Ability to be productive and successful in a fast-paced work environment.
Self-directed, self-motivated and detail-oriented nature; willing to proactively assume responsibility for and consistently follow through on assignments.
Demonstrate honesty, dedication, cooperation, positive attitude, adaptability and flexibility with changes in responsibilities and duties.
Bachelor’s degree or Associate’s degree preferred.
About Mirati Therapeutics
Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRASG12D inhibitor, and other oncology discovery programs. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics, visit us atMirati.comor follow us on Twitterand LinkedIn.
Why Join?
At Mirati, we have an unapologetic and relentless focus on our mission to transform the lives of patients with cancer and their loved ones. Patients and their families motivate us to work smarter, faster and better. We are driven by the knowledge that our efforts can one-day deliver life-saving therapies for the people who need us most. Urgency, open-mindedness, accountability and collaboration ground our work. These shared values are central to who we are, what we do and how we do it.
Our people fuel our success. They are fearless and passionate in their daily pursuit of our mission. We are committed to continuing to create a company and experience that attracts and keeps the best people. When you want your days to count and the work you do to matter, discovering and delivering potentially life-changing therapies is more than a job, it’s the chance to be part of something bigger.
We believe diverse professional experiences and an inclusive culture can drive better outcomes for patients. We want employees to be authentic and use their perspectives to contribute to our mission in a meaningful way.
Mirati cultivates an environment where:
An entrepreneurial attitude is encouraged
Our people are empowered to speak up, embrace the gray and achieve solutions
Diverse experiences are an important of part making the best decisions
We laugh and have fun as a work family
No matter the role, we are unified by our passion for helping patients, and are inspired by a single vision – to unlock the science behind the promise of a life beyond cancer. Together, we own Mirati’s success.
Mirati is an Equal Opportunity Employer (EOE) – we celebrate diverse experiences without regard to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic information, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
Mirati is looking for a talented Medical Director to join the Clinical team. The successful candidate will have a passion for novel science, an affinity for strategic thinking, looking beyond the day-to-day execution, and will have a track record of keeping clinical programs on track and hitting milestones. The position will provide key overall clinical, scientific and/or logistical support to clinical development programs and is responsible for the compliance of the program to regulatory standards and procedures and will be graded according to the level of experience of the successful candidate.
Your Responsibilities
Clinical leadership of global oncology clinical trials (Phase 1-3), ensuring that studies are carried out in accordance with the clinical development plan, GCPs, ICH and FDA and other regulatory authority requirements.
Help identify global study sites and foster relationships with study investigators
As the primary medical monitor for assigned study(ies), be the first point of contact with sites; answer site questions about eligibility, enrollment; safety and patient management
Chair internal and external clinical trial meetings-updating clinical staff and upper management on patient recruitment, trial issues, investigator’s feedback, patient enrollment issues and presenting a plan of action for resolution of issues
Production of clinical documents required for the conduct of clinical studies, such as clinical protocols (and amendments as needed), informed consent documents, investigator’s brochures, and safety management plans in compliance with regulations and good clinical practices
Preparation of abstracts and posters for scientific meetings
Preparation of slides/ presentation at internal and external meetings, such as team meetings, Advisory Boards and Board of Director Meetings
Lead ongoing data interpretation to understand safety and efficacy profile of the investigational drug
Assist in preparation of clinical sections of key regulatory documents, e.g., IND annual reports and briefing packages
Present aspects of clinical program at Site Initiation Visits, Investigator’s Meetings and scientific conferences
Maintain state-of-the-art knowledge of the principles and theory in relevant therapeutic areas
Assist in case report form (CRF) development and data analysis plans
Review project specifications for IRT/IXRS, ePRO, Imaging Charter for Central radiology review and other procedural documents
Perform in data cleaning and clinical study report review
Review and approve study materials such as CRFs, patient diaries, drug accountability forms, study reference manuals
Assist in generation and update of Clinical Development Plan (CDP)
Perform all duties in keeping with the Company’s core values, policies and all applicable regulations.
What is Required
Medical Doctor (M.D.), either with Board Certification in Medical Oncology/ Hematology Oncology or Internal Medicine
5+ years of clinical development experience in the pharmaceutical or biotechnology industries with at least 2 years involvement in oncology drug development
Thorough working knowledge / understanding of clinical trial design, methodology and statistical concepts.
Working knowledge of the IND/NDA process preferred.
In-depth knowledge of GCP/ICH guidelines preferred.
Proven ability to interact with different functional groups, investigators, key opinion leaders and the medical/scientific community.
Available for ~ 25% travel, including overnight stays.
Strong written and verbal communication skills required.
Ability to thrive in a fast-paced, dynamic small company environment with ability to adjust workload based upon changing priorities.
Leadership skills including a collaborative and team-oriented approach.
Good organizational, time management and interpersonal skills.
Demonstrated excellence in management skills, with track record of successfully managing multiple projects, trials, and priorities.
Ability to work well with global, multi-disciplinary teams.
About Mirati Therapeutics
Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRAS G12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRAS G12D inhibitor, and other oncology discovery programs. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics, visit us atMirati.comor follow us on Twitterand LinkedIn.
Why Join?
At Mirati, we have an unapologetic and relentless focus on our mission to transform the lives of patients with cancer and their loved ones. Patients and their families motivate us to work smarter, faster and better. We are driven by the knowledge that our efforts can one-day deliver life-saving therapies for the people who need us most. Urgency, open-mindedness, accountability and collaboration ground our work. These shared values are central to who we are, what we do and how we do it.
Our people fuel our success. They are fearless and passionate in their daily pursuit of our mission. We are committed to continuing to create a company and experience that attracts and keeps the best people. When you want your days to count and the work you do to matter, discovering and delivering potentially life-changing therapies is more than a job, it’s the chance to be part of something bigger.
We believe diverse professional experiences and an inclusive culture can drive better outcomes for patients. We want employees to be authentic and use their perspectives to contribute to our mission in a meaningful way.
Mirati cultivates an environment where:
An entrepreneurial attitude is encouraged
Our people are empowered to speak up, embrace the gray and achieve solutions
Diverse experiences are an important of part making the best decisions
We laugh and have fun as a work family
No matter the role, we are unified by our passion for helping patients, and are inspired by a single vision – to unlock the science behind the promise of a life beyond cancer. Together, we own Mirati’s success.
Mirati is an Equal Opportunity Employer (EOE) – we celebrate diverse experiences without regard to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic information, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
The Associate Director, SEC Reporting & Technical Accounting will oversee the SEC reporting function, technical accounting research and positions, and SOX compliance of Mirati Therapeutics, Inc. (the “Company”). This role will require a deep understanding of U.S. GAAP, SEC guidance and SOX 404 requirements, strong analytical skills, written and verbal communication skills, and an ability to develop relationships and work cross-functionally. The ideal candidate is highly motivated, detail-oriented, and can help identify and develop best processes and practices to help support growth of our team and the Company.
Your Responsibilities
Plan, coordinate and execute all external, SEC financial reporting processes and initiatives, including related activities such as:
prepare annual, quarterly and periodic reports (i.e., 10-K, 10-Q and 8-K), and coordinate reviews and lead meeting discussions over such documents with the Executive Leadership Team, Disclosure Committee, Audit Committee, and external auditors
prepare the Company’s annual proxy statement, including the related directors’ and officers’ questionnaires, ensuring compliance with all disclosure requirements and coordinating the annual meeting of shareholders
prepare financial analyses and ad-hoc materials for audit committee and board of director meetings
Perform technical accounting research around new accounting standards and complex accounting issues, and prepare technical memorandums to support the Company’s positions
Key team member for first time commercial launch biotech company, evaluating accounting standards, disclosures, and our internal control environment for product sales, inventory, and gross-to-net considerations
Lead SOX 404b compliance efforts, by designing and implementing new internal controls as needed, monitoring ongoing performance and compliance of the Company’s SOX procedures, ensuring appropriate documentation (narratives, risk assessments, testing results etc.), and identifying exceptions and conducting remediation efforts as needed.
Coordinate directly with external auditors and facilitate quarterly review and year-end audit procedures
Proactively strive for process improvements to enhance financial reporting processes and implement best practices
Assist with monthly accounting close duties, as needed
Lead other special projects as required, and other duties to support the finance function
What is Required
10+ years of accounting experience; combination of public accounting / life sciences industry experience is ideal.
CPA Required
Experience with Workiva, Active Disclosure, or other financial reporting platform
Experience working in a SOX 404(b) compliant environment
Substantial experience with and knowledge over U.S. GAAP, SEC guidance and SOX 404 requirements
Experience at a commercial biotechnology company is a plus
Strong time management and organizational skills
High degree of attention to detail
Strong written and verbal communication skills
Ability to work independently and prioritize tasks
About Mirati Therapeutics
Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRAS G12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRAS G12D inhibitor, and other oncology discovery programs. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics, visit us atMirati.comor follow us on Twitterand LinkedIn.
Why Join?
At Mirati, we have an unapologetic and relentless focus on our mission to transform the lives of patients with cancer and their loved ones. Patients and their families motivate us to work smarter, faster and better. We are driven by the knowledge that our efforts can one-day deliver life-saving therapies for the people who need us most. Urgency, open-mindedness, accountability and collaboration ground our work. These shared values are central to who we are, what we do and how we do it.
Our people fuel our success. They are fearless and passionate in their daily pursuit of our mission. We are committed to continuing to create a company and experience that attracts and keeps the best people. When you want your days to count and the work you do to matter, discovering and delivering potentially life-changing therapies is more than a job, it’s the chance to be part of something bigger.
We believe diverse professional experiences and an inclusive culture can drive better outcomes for patients. We want employees to be authentic and use their perspectives to contribute to our mission in a meaningful way.
Mirati cultivates an environment where:
An entrepreneurial attitude is encouraged
Our people are empowered to speak up, embrace the gray and achieve solutions
Diverse experiences are an important of part making the best decisions
We laugh and have fun as a work family
No matter the role, we are unified by our passion for helping patients, and are inspired by a single vision – to unlock the science behind the promise of a life beyond cancer. Together, we own Mirati’s success.
Mirati is an Equal Opportunity Employer (EOE) – we celebrate diverse experiences without regard to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic information, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
The Director, Compliance will assist with the development and implementation of a healthcare compliance program at Mirati, including being responsible for the implementation of systems, programs, processes, and practices to ensure that the Company is in compliance with legal and regulatory requirements and its policies. The Director, Compliance will provide a broad range of compliance support throughout Mirati’s organization; partnering with the business to sustain Mirati’s ethical and compliant culture and develop practical ways to uphold the legal, regulatory, and ethical obligations of a pharmaceutical company
Your Responsibilities
Independently drive the development, implementation, and management of the compliance program, including policy, process, training, communication, auditing, monitoring, and investigations
Lead and manage all compliance operations activities including providing compliance oversight and participating, as required, in review and approval processes for core Commercial and Medical activities: grants, sponsorships, speaker bureau, advisory boards and other initiatives involving interactions with healthcare professionals, healthcare organizations and patients/advocacy groups.
Develop and be responsible for oversight of the company’s compliance auditing and monitoring program; including:
Assessing organizational compliance risk in creating and updating a risk-based audit and monitoring plan. Partnering with the business to address detected noncompliance including recommending and taking corrective actions when needed
Track and report results of compliance investigations and the corrective actions taken to Compliance leadership and other internal key stakeholders as needed. Interpret findings/trends and carry out corrective action and retraining as needed
Develop and oversee a comprehensive compliance training program and communication strategy to U.S. employees and designated third parties on applicable compliance policies, laws and regulations, including any new developments or updates that may impact the Company’s compliance program.
Create and lead the transparency reporting program, including developing, reviewing, and submitting reports related to federal and state transparency (“Sunshine”) laws.
Monitor the business developments and industry compliance best practices to evolve the compliance program through ensuring appropriate practices, processes, systems and tools are in place and maintained to support the business at all times.
Be an ambassador for communication around key compliance topics, resources, and special initiatives
What is Required
Bachelor’s degree and 10 years’ experience or any combination of education and experience providing equivalent background.
Certification in Healthcare Compliance (CHC) preferred
Working knowledge and previous experience in a compliance operations or project management position desired
Excellent interpersonal, communication and written skills, proven ability to work independently with a wide range of stakeholders.
Strong presentation and training skills and ability to work independently.
Interact with employees and manage vendors
Up to 20% travel may be required.
Role will be remote.
About Mirati Therapeutics
Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRAS G12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRAS G12D inhibitor, and other oncology discovery programs. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics, visit us atMirati.comor follow us on Twitterand LinkedIn.
Why Join?
At Mirati, we have an unapologetic and relentless focus on our mission to transform the lives of patients with cancer and their loved ones. Patients and their families motivate us to work smarter, faster and better. We are driven by the knowledge that our efforts can one-day deliver life-saving therapies for the people who need us most. Urgency, open-mindedness, accountability and collaboration ground our work. These shared values are central to who we are, what we do and how we do it.
Our people fuel our success. They are fearless and passionate in their daily pursuit of our mission. We are committed to continuing to create a company and experience that attracts and keeps the best people. When you want your days to count and the work you do to matter, discovering and delivering potentially life-changing therapies is more than a job, it’s the chance to be part of something bigger.
We believe diverse professional experiences and an inclusive culture can drive better outcomes for patients. We want employees to be authentic and use their perspectives to contribute to our mission in a meaningful way.
Mirati cultivates an environment where:
An entrepreneurial attitude is encouraged
Our people are empowered to speak up, embrace the gray and achieve solutions
Diverse experiences are an important of part making the best decisions
We laugh and have fun as a work family
No matter the role, we are unified by our passion for helping patients, and are inspired by a single vision – to unlock the science behind the promise of a life beyond cancer. Together, we own Mirati’s success.
Mirati is an Equal Opportunity Employer (EOE) – we celebrate diverse experiences without regard to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic information, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
The Sr Manager, FP&A will be a Finance Business Partner between Finance and the Clinical Operations Teams. This position will drive financial planning and forecasting by working cross-functionally to support our clinical studies and major business initiatives. The role will focus on the analytics that support budgets, forecasting, financial reporting and program management. The Sr Manager, FP&A will be a hands-on resource to senior management, clinical operations department heads and program leads.
Your Responsibilities
Develop and coordinate financial budgets and forecasts for the organization.
Participate in the budgeting/forecasting process; includes owning financial reporting in partnership with Program Team Leaders, Program Team Members and Clinical Operations Department Heads. Thus, ensuring financial information (budget vs actual) and other key performance indicators are provided on a monthly basis in order to effectively manage the active programs and the business as a whole.
Ensure all key topics are raised proactively and aligned with stakeholders to minimize surprises.
Prepare monthly reporting packages that include full financial statements, key performance indicators, key business trends, actual vs budget/forecast variances and comprehensive explanations of key differences for assigned functional areas.
Work closely with Clinical Operations Department Heads to perform budget re-forecasting on an as required basis.
Work closely with Clinical Operations Department Heads to develop and review customized financial reporting to support clinical trials and associated activities.
Develop financial models and productivity tools to help make responsible financial decisions. Recommend enhancements to the financial planning and budgeting process and system that effectively generate program and activity-based reporting to meet internal business and SEC reporting requirements.
Provide accounting support in connection with the monthly close process and coordinate with Accounting to drive Balance Sheet and P&L accuracy and control.
Perform all duties in keeping with the Company’s core values, policies and all applicable regulations.
What is Required
Bachelor’s degree in Finance, Accounting, Business Administration or science-related field (Master’s Degree or CPA Preferred).
7+ years of relevant experience.
Proven experience utilizing advanced Excel skills to interpret large amounts of data.
Financial Planning systems knowledge; Adaptive Insights preferred.
Experience providing financial support in the biotechnology/pharmaceutical industries, specifically supporting clinical operations
Understanding of GAAP and key accounting principles.
Excellent interpersonal skills, along with the ability to work effectively with multiple functional areas in a collaborative, team environment.
Strong verbal and written communication skills.
Ability to thrive in a fast-paced ever-changing environment.
Alignment with Mirati’s culture and values.
About Mirati Therapeutics
Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRASG12D inhibitor, and other oncology discovery programs. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics, visit us atMirati.comor follow us on Twitterand LinkedIn.
Why Join?
At Mirati, we have an unapologetic and relentless focus on our mission to transform the lives of patients with cancer and their loved ones. Patients and their families motivate us to work smarter, faster and better. We are driven by the knowledge that our efforts can one-day deliver life-saving therapies for the people who need us most. Urgency, open-mindedness, accountability and collaboration ground our work. These shared values are central to who we are, what we do and how we do it.
Our people fuel our success. They are fearless and passionate in their daily pursuit of our mission. We are committed to continuing to create a company and experience that attracts and keeps the best people. When you want your days to count and the work you do to matter, discovering and delivering potentially life-changing therapies is more than a job, it’s the chance to be part of something bigger.
We believe diverse professional experiences and an inclusive culture can drive better outcomes for patients. We want employees to be authentic and use their perspectives to contribute to our mission in a meaningful way.
Mirati cultivates an environment where:
An entrepreneurial attitude is encouraged
Our people are empowered to speak up, embrace the gray and achieve solutions
Diverse experiences are an important of part making the best decisions
We laugh and have fun as a work family
No matter the role, we are unified by our passion for helping patients, and are inspired by a single vision – to unlock the science behind the promise of a life beyond cancer. Together, we own Mirati’s success.
Mirati is an Equal Opportunity Employer (EOE) – we celebrate diverse experiences without regard to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic information, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
As Sr. Programmer, Statistical Programming you will lead programming support for multiple complex oncology studies in multiple stages of clinical development. This role will interact with Biostatistics, Clinical Data Management, Medicals, Clinical Operations and Regulatory to design, write, and validate SAS® programs in accordance with company, industry, and regulatory requirements; you will play a key role in developing, implementing and evaluating statistical programming standards and processes
Your Responsibilities
Lead programming support for multiple complex oncology studies, provide input to timeline development, and resource assessment
Create/review programming plan, specifications for datasets and TLFs. Advanced knowledge with CDISC conventions, i.e., SDTM and ADaM models and experienced in implementing these models
Develop and validate SAS® programs to produce high quality deliverables for in-house projects within set timelines in accordance with company and regulatory requirements. The deliverables include SDTM and ADaM datasets, define.xml, tables, listings and figures
Perform conformance checking of SDTM and ADaM datasets using Pinnacle 21; recommend/implement solutions to identified issues; ensure datasets are in compliance with submission standards
Manage CRO programming activities; review and validate deliverables produced by CROs, independently provide solutions to issues raised by CROs
Lead the creation and review of analysis file specification for ISS and ISE; program and validate ISS and ISE
Having advanced level of programming expertise, create and validate SAS macros and utilities to automate standard and frequent tasks
Create/oversee the creation of proper documentation related to statistical programs, datasets, review guides and QC documentation, ensure documentations are in compliance with SOPs and/or meeting submission requirements
Review and provide input on documents produced by other Biometric functions such as: statistical analysis plans; TFL shells; data management plans; data transfer plans and case report forms
Contribute to the development, implementation and continuous improvement of programming processes and standard
Effectively communicate in a project team environment, within department, among functional groups and external collaborators
Perform other programming duties as assigned
What is Required
Minimum of BS required in Computer Science, Statistics, Life Sciences or other related field
BS with 6+ years or MS with 4+ years of SAS programming experience in drug development in CRO or pharma/biotech company
Good written and verbal communication skills
Oncology experience preferred, and submission experience is a plus
About Mirati Therapeutics
Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRASG12D inhibitor, and other oncology discovery programs. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics, visit us atMirati.comor follow us on Twitterand LinkedIn.
Why Join?
At Mirati, we have an unapologetic and relentless focus on our mission to transform the lives of patients with cancer and their loved ones. Patients and their families motivate us to work smarter, faster and better. We are driven by the knowledge that our efforts can one-day deliver life-saving therapies for the people who need us most. Urgency, open-mindedness, accountability and collaboration ground our work. These shared values are central to who we are, what we do and how we do it.
Our people fuel our success. They are fearless and passionate in their daily pursuit of our mission. We are committed to continuing to create a company and experience that attracts and keeps the best people. When you want your days to count and the work you do to matter, discovering and delivering potentially life-changing therapies is more than a job, it’s the chance to be part of something bigger.
We believe diverse professional experiences and an inclusive culture can drive better outcomes for patients. We want employees to be authentic and use their perspectives to contribute to our mission in a meaningful way.
Mirati cultivates an environment where:
An entrepreneurial attitude is encouraged
Our people are empowered to speak up, embrace the gray and achieve solutions
Diverse experiences are an important of part making the best decisions
We laugh and have fun as a work family
No matter the role, we are unified by our passion for helping patients, and are inspired by a single vision – to unlock the science behind the promise of a life beyond cancer. Together, we own Mirati’s success.
Mirati is an Equal Opportunity Employer (EOE) – we celebrate diverse experiences without regard to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic information, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
Mirati is seeking an Sr. Cloud Systems Administrator who has extensive experience working with Microsoft’s Azure platform and enterprise application services to support the IT leadership team in executing the roadmap for IT infrastructure and cloud operations. This role’s primary focus is on ensuring technology resources are distributed, maintained, secured, configured, and effectively utilized across Mirati’s growing network.
This is a technical role that requires hands-on knowledge of different areas within the cloud arena such as user management, authentication (e.g. Okta, Azure MFA), orchestrate VDIs Linux/Window/Images, cloud enterprise collaboration tools (Teams, SharePoint, OneDrive, Power Platform), cloud infrastructure architecture on AWS and Azure, scripting (PowerShell, bash, Azure cli), cloud and on-premise storage, backups, device management platforms (e.g Intune, Business Manager, Airwatch ), reporting, metric analysis, and familiarity with networking and wireless.
The ideal candidate will be passionate about information technology (IT) operations, providing reliable and secure infrastructure and networking platforms in support of Mirati’s critical business solutions. They should have an excellent ability to communicate, organize, document, and solve problems using their in-depth understanding of information systems. They will also be able to use their technical experience and business acumen to maintain a trusted relationship with end-users and business partners, while enabling technical teams to deliver and maintain quality solutions aligned with Mirati’s organizational goals.
Your Responsibilities
Troubleshoot and document deployment and system issues
Follow-up on alerts and notifications
Responsible for performance metrics, analysis, and uptime
Configure, secure, and maintain Infrastructure as a Service (IaaS)
Provide technical support to Mirati’s end-users’ through our ticketing system
Write and document code/instructions to automate system architectures
Working on custom special projects as assigned
Work with the Network Administrator to document, maintain and support networking efforts
Understands Azure platform and architecture, documents, and supports the underlying business processes, workflows, data and application platforms that depends on Microsoft and 3rd party services
Take ownership of issues, with a sense of urgency, and using sound judgment to resolve
SQL server maintenance and support
Firewall maintenance and support
Server documentation, installation, support, maintenance
Backup documentation and maintenance
Responsible for tracking licenses, metrics, and reporting
Engage peers in accordance with processes and procedures to document and contribute to solution/architecture designs
What is Required
Minimum 4 years’ experience in a similar role
The ability to communicate to technical teams as well as non-technical resources.
Strong working knowledge of Azure’s platform (M365, Exchange Online, SharePoint, Teams, Azure Active Directory, Power platform, SAML, Defender, SQL databases, Azure Storage, Virtual Network, VPN and Gateways, Powershell/Azure Cli); knowledge of Security and Compliance Center highly desired.
Strong knowledge of Azure/AWS infrastructure and architecture
Experience with the implementation, integration, management, and support of hybrid environments where SaaS, PaaS, and IaaS solutions, and virtualized and cloud-based infrastructure, are incorporated as required.
Strong working knowledge and proven working experience with the following: Windows, Linux, Unix, Storage, VDI, Active Directory, VMware, AWS, Azure, and hardware such as Dell and Cisco/Meraki.
Sound technical skills in networking (DNS, DHCP, remote user support, etc.) and experience with circuits, routers, switches, and ISP responsibilities and relationships.
Experience in the pharmaceutical industry is highly desirable.
Strong detail and organized documentation/technical writing
Strong verbal communication skills
Has a strong understanding and competency in IAM, resource monitoring and resource groups, mapping dependencies, and scripting
About Mirati Therapeutics
Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRAS G12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRAS G12D inhibitor, and other oncology discovery programs. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics, visit us atMirati.comor follow us on Twitterand LinkedIn.
Why Join?
At Mirati, we have an unapologetic and relentless focus on our mission to transform the lives of patients with cancer and their loved ones. Patients and their families motivate us to work smarter, faster and better. We are driven by the knowledge that our efforts can one-day deliver life-saving therapies for the people who need us most. Urgency, open-mindedness, accountability and collaboration ground our work. These shared values are central to who we are, what we do and how we do it.
Our people fuel our success. They are fearless and passionate in their daily pursuit of our mission. We are committed to continuing to create a company and experience that attracts and keeps the best people. When you want your days to count and the work you do to matter, discovering and delivering potentially life-changing therapies is more than a job, it’s the chance to be part of something bigger.
We believe diverse professional experiences and an inclusive culture can drive better outcomes for patients. We want employees to be authentic and use their perspectives to contribute to our mission in a meaningful way.
Mirati cultivates an environment where:
An entrepreneurial attitude is encouraged
Our people are empowered to speak up, embrace the gray and achieve solutions
Diverse experiences are an important of part making the best decisions
We laugh and have fun as a work family
No matter the role, we are unified by our passion for helping patients, and are inspired by a single vision – to unlock the science behind the promise of a life beyond cancer. Together, we own Mirati’s success.
Mirati is an Equal Opportunity Employer (EOE) – we celebrate diverse experiences without regard to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic information, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
Our mission is to discover, design, and deliver breakthrough therapies to transform the lives of cancer patients and their loved ones. We have built a culture fueled by accountability, urgency, collaboration and open-mindedness, and have established ourselves as an innovator within our industry. As we grow, we are looking to build diverse teams, with skilled individuals that are passionate about their work.
Why join us?
The Principal Scientist, Product Development will be responsible for design and development of small molecule oral solid dosage drug products for different phases of clinical studies and commercialization. He/she will serve as a subject matter expert in product development related activities for new product introductions, and product lifecycle. He/she will provide technical expertise towards formulation, process development, scale-up and tech-transfer activities conducted in-house and at external contract development & manufacturing organizations (CDMO’s). He/she will work effectively with cross-functional groups, including analytical development, process chemistry, clinical, quality, regulatory, and supply chain to ensure that drug products are developed and manufactured in compliance with all applicable regulations and corporate procedures (GLP, GMP, ICH).
Your Responsibilities:
Design and develop optimal formulations, and robust, scalable and cost-effective processes for the manufacture of drug products for clinical studies and commercialization. Design and implement efficient DOE’s to support formulation and process robustness.
Support material characterization efforts such as solid state form, mechanical attributes, particle size assessment, and physicochemical stability. Collaborate effectively with API process chemistry group to ensure drug substance with optimal physico-chemical properties is advanced towards commercialization.
Support preclinical team in the production of optimal formulations and preparation procedures for toxicology and DMPK studies. Provide technical inputs for clinical dosage form bridging strategies and to manage potential scale-up and post-approval changes.
Lead screening, selecting, and managing drug product manufacturing sites/technologies (CDMOs) of oral solid dosage drug products.
Lead process scale-up and tech-transfer of various pharmaceutical unit operations using Quality by Design (QbD) elements such as FMEA, Design of Experiments (DoEs), statistical analysis, first principles, and process modeling.
Late stage drug product Subject Matter Expert for oral solid dosage forms, providing technical direction during drug product development at Mirati R&D lab and at CDMOs.
Author / review manufacturing batch records and study protocols. Author / coordinate preparation of high-quality technical reports and integrated project summaries.
Author/ review CMC regulatory documentation for IND, IMPD, NDA, and MAA filings, covering all phases of clinical development and commercial launch. Assist during quality events (QEs) or failure investigations and implementation of CAPAs at contractor sites.
Support design of primary, secondary, and tertiary packaging/labeling solutions for drug products. Support related activities for qualification and validation in collaboration with supply chain and quality functions.
Lead drug product post-launch assessments such as Continued Process Verification (CPV) and Continuous Process Improvement (CPI) by utilizing technological innovation and Lean Six Sigma methodologies.
Build strong relationships with contract manufacturing partners, contract manufacturing Quality, and drug product manufacturing process technical teams. Support evaluation of product impact from manufacturing processes, production scale, equipment, and raw material changes.
Maintain up-to date scientific knowledge of pharmaceutical process engineering through regular literature review and participation in conferences/industry consortium to keep Mirati at the forefront of manufacturing best practices, technology trends and innovative solutions.
What is Required:
Relevant degree in Chemical Engineering, Pharmaceutical Sciences, Pharmaceutics, Industrial Pharmacy, or other life sciences related fields to include: Doctorate (Ph.D.) with 8+, Masters (M.S.) with 12+, or Bachelor (B.S.) with 15+ years of experience in Pharmaceutical industry.
Technical expertise in formulation design, process development, process scale-up and technology transfer of conventional and enabling solid oral dosage forms using FDA/ICH guidance and Quality by Design (QbD) principles such as DoE, statistical analysis, first principles, modeling, and FMEA/Risk Assessment tools.
Strong knowledge and hands-on experiences in conventional and enabling oral dose manufacturing unit operations such as: Dry/Wet Granulation, Milling, Blending, Compression, Film Coating, Spray Drying, Nano-Milling, and Twin Screw Extrusion.
Robust understanding of material science and linkage to manufacturing process and product performance. Experience in use of applied science during manufacturing troubleshooting, gap analysis, root cause analysis, and risk assessment.
Experience in authoring CMC sections of regulatory dossiers (including NDAs and MAAs) with proven track record. Knowledge of cGMP requirement for drug product development and manufacturing.
Hands-on experience in Process Validation (PPQ), and post approval changes according to FDA and ISPE guidelines. Experience in use of statistical tools in data trending for process performance characterization, process capability analysis, and CPV/CPI during product life cycle.
Excellent interpersonal skills with the ability to interact professionally and effectively with peers, management, and leadership both within and outside the company. Experience in project management and ability to work in a cross-functional working groups.
Excellent verbal and written communication skills with strong technical report writing.
Ability to travel up to 35% domestically and internationally.
Mirati’s policy is to provide equal employment opportunities to all applicants and employees without regards to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic informations, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
About Mirati Therapeutics
Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRASG12D inhibitor, and other oncology discovery programs. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics, visit us atMirati.comor follow us on Twitterand LinkedIn.
Why Join?
At Mirati, we have an unapologetic and relentless focus on our mission to transform the lives of patients with cancer and their loved ones. Patients and their families motivate us to work smarter, faster and better. We are driven by the knowledge that our efforts can one-day deliver life-saving therapies for the people who need us most. Urgency, open-mindedness, accountability and collaboration ground our work. These shared values are central to who we are, what we do and how we do it.
Our people fuel our success. They are fearless and passionate in their daily pursuit of our mission. We are committed to continuing to create a company and experience that attracts and keeps the best people. When you want your days to count and the work you do to matter, discovering and delivering potentially life-changing therapies is more than a job, it’s the chance to be part of something bigger.
We believe diverse professional experiences and an inclusive culture can drive better outcomes for patients. We want employees to be authentic and use their perspectives to contribute to our mission in a meaningful way.
Mirati cultivates an environment where:
An entrepreneurial attitude is encouraged
Our people are empowered to speak up, embrace the gray and achieve solutions
Diverse experiences are an important of part making the best decisions
We laugh and have fun as a work family
No matter the role, we are unified by our passion for helping patients, and are inspired by a single vision – to unlock the science behind the promise of a life beyond cancer. Together, we own Mirati’s success.
Mirati is an Equal Opportunity Employer (EOE) – we celebrate diverse experiences without regard to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic information, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
The Associate Scientific Director will be responsible for parenteral formulation and process development of Mirati’s new chemical entities (NCEs) utilizing internal laboratories and external resources. The individual will be responsible for conducting targeted preformulation studies, preparing pre-clinical formulations for toxicology and PK assessments, and developing product for first-in-human (FIH) and early-stage clinical studies. The incumbent will engage in developments, tech-transfer activities and GMP manufactures of clinical trial materials (CTMs) at contract development and manufacturing organizations (CDMOs).
Your Responsibilities
Plan and conduct research studies to support preformulation, formulation, and process developments of injectable dosage formsfor early-stage clinical studies (first-in-human, Phase I-II).
Design prototype formulations and manufacturing processes, conduct in-house experiments, and transfer such technology to CDMO/CMO for manufacturing CTM.
Develop and prepare in-house pre-clinical formulations to enable PK/PD and toxicology studies.
Manage program activities with key suppliers and external manufacturing partners including coordination, communication, and technical oversight to ensure timely execution of deliverables.
Generate high quality data based on sound scientific principles and prepare data summaries, technical reports, scientific presentations, and regulatory documents.
Collaborate with internal and external stakeholders to support project plans and schedules ensuring that tasks are executed in accordance with operational plans, cGMP requirements and regulatory commitments.
What is Required
PhD. degree in Pharmaceutical Sciences or related a scientific discipline with 10+ years of experience, or M.S. degree with 15+ years of experience in pharmaceutical industry related to formulation and process development.
Expertise in parenteral dosage form development of small molecules for early clinical studies of first-in-human (FIH) and Phase I/II is required. Added experience with oral drug product platforms is a plus.
Hands on experience in parenteral formulation development utilizing one or more complex injectable drug delivery technologies such as liposome, nanoparticle albumin bound (nab), lipid microspheres, phospholipid gel, emulsion, suspension and lyophilization of injectable drug products is required.
Ability to interpret the preformulation data package to understand the physicochemical properties of drug, drug solubilization, chemical degradation and physicochemical stability of drug substance and drug products.
Robust understanding of formulation and process development aspects (e.g. DOE experiments) and scaleup activities for manufacturing GMP clinical supplies.
Knowledgeable in operating principles and troubleshooting of equipment required for manufacturing sterile injectable drug products.
Demonstrated ability to work effectively in a fast-paced and team-oriented environment.
Must be well organized, proactive, and detail oriented.
Ability to multi-task and work efficiently in an agile environment.
Strong interpersonal, communication, and collaboration skills along with strengths in delivering results on-time.
Ability to travel up to 25% domestically and internationally.
Role will be based at Company HQ site in San Diego and requires COVID-19 vaccination or weekly negative COVID-19 test result.
About Mirati Therapeutics
Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. Mirati is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRASG12D inhibitor, and other oncology discovery programs. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
For more information about Mirati Therapeutics, visit us atMirati.comor follow us on Twitterand LinkedIn.
Why Join?
At Mirati, we have an unapologetic and relentless focus on our mission to transform the lives of patients with cancer and their loved ones. Patients and their families motivate us to work smarter, faster and better. We are driven by the knowledge that our efforts can one-day deliver life-saving therapies for the people who need us most. Urgency, open-mindedness, accountability and collaboration ground our work. These shared values are central to who we are, what we do and how we do it.
Our people fuel our success. They are fearless and passionate in their daily pursuit of our mission. We are committed to continuing to create a company and experience that attracts and keeps the best people. When you want your days to count and the work you do to matter, discovering and delivering potentially life-changing therapies is more than a job, it’s the chance to be part of something bigger.
We believe diverse professional experiences and an inclusive culture can drive better outcomes for patients. We want employees to be authentic and use their perspectives to contribute to our mission in a meaningful way.
Mirati cultivates an environment where:
An entrepreneurial attitude is encouraged
Our people are empowered to speak up, embrace the gray and achieve solutions
Diverse experiences are an important of part making the best decisions
We laugh and have fun as a work family
No matter the role, we are unified by our passion for helping patients, and are inspired by a single vision – to unlock the science behind the promise of a life beyond cancer. Together, we own Mirati’s success.
Mirati is an Equal Opportunity Employer (EOE) – we celebrate diverse experiences without regard to race, color, religion, creed, gender identity or expression, age, national origin or ancestry, citizenship, disability, sexual orientation, marital status, pregnancy, veteran status, membership in the uniformed services, genetic information, or any other basis protected by applicable law.
Notice to Third Party Agencies: Please note that Mirati Therapeutics Inc. does not accept unsolicited resumes from recruiters or employment agencies.
#LI-On-site
References
Ledford, Heidi. “Cancer: The Ras renaissance.” Nature 520.7547 (2015): 278-280.
Matikas, Alexios et al. “Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entity.” Crit Rev Oncol Hematol 110 (2017): 1-12.
Ostrem, Jonathan M., Shokat, Kevan M. “Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.” Nat Rev Drug Discov 15.11 (2016): 771-785.
Bos, Johannes L. “ras oncogenes in human cancer: a review.” Cancer Res 49.17 (1989): 4682-4689
Simanshu, Dhirendra K. et al. “RAS proteins and their regulators in human disease.” Cell 170.1 (2017): 17-33.
Beganoyic S. CLINICAL SIGNIFICANCE OF THE KRAS MUTATION. Bosn J Basic Med Sci. 2009;9(Suppl 1):S17-S20.
Mirati estimates based on epidemiology data reported in Globocan 2022 (accessed 2019) and frequencies by mutation; Europe includes EU, Russia and 10 additional European countries; RET estimate does not include thyroid cancer. Rounded to the nearest 1,000.
Zehir A et al, Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23(6):703-713”
Campbell et al, Nature Genetics 2016 “Distinct patterns of somatic genome alterations in lung adenocarcinomas”
Bailey P et al, Nature 2016 “Genomic analyses identify molecular subtypes of pancreatic cancer”
Hallin J. The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients. Cancer Discovery, 2019.
Mirati Therapeutics. Data on File.
Percent et al. Phase III trial of sitravatinib plus nivolumab vs. docetaxel for treatment of NSCLC after platinum-based chemotherapy and immunotherapy (SAPPHIRE). Journal of Clinical Oncology 2020 38:15_suppl, TPS9635-TPS9635.
Pircher et al., Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints. Int J Mol Sci, 2017. 18(11).
Akalu, Y.T., C.V. Rothlin, and S. Ghosh, TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy. Immunol Rev, 2017. 276(1): p. 165-177.
Kwilas, A.R., R.N. Donahue, K.Y. Tsang, and J.W. Hodge, Immune consequences of tyrosinekinase inhibitors that synergize with cancer immunotherapy. Cancer Cell Microenviron, 2015.
Kryukov GV, Wilson FH, Ruth JR, et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science. 2016;351(6278):1214-1218. doi:10.1126/science.aad5214
Marjon K, Cameron MJ, Quang P, et al. MTAP deletions in cancer create vulnerability to targeting of the MAT2A/PRMT5/RIOK1 axis. Cell Rep. 2016;15(3):574-587. doi:10.1016/j.celrep.2016.03.043
Mavrakis KJ, McDonald ER 3rd, Schlabach MR, et al. Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5. Science. 2016;351(6278):1208-1213. doi:10.1126/science.aad5944
Han G, Yang G, Hao D, et al. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nat Commun. 2021 Sep 23;12(1):5606. doi: 10.1038/s41467-021-25894-9.
Smith C.R., Aranda R, Bobinski T.P., Briere D.M., Burns A.C., et al. Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers. J Med Chem. 2022 Jan 18. doi: 10.1021/acs.jmedchem.1c01900. Online ahead of print.
